Litigation Details for RxOmeg Therapeutics, LLC v. Granules Pharmaceuticals, Inc. (D. Del. 2020)
✉ Email this page to a colleague
RxOmeg Therapeutics, LLC v. Granules Pharmaceuticals, Inc. (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-07-01 |
| Court | District Court, D. Delaware | Date Terminated | 2022-03-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
| Jury Demand | None | Referred To | |
| Parties | RXOMEG THERAPEUTICS, LLC | ||
| Patents | 10,226,423; 9,907,751 | ||
| Attorneys | Gary A. Coad | ||
| Firms | Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in RxOmeg Therapeutics, LLC v. Granules Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for RxOmeg Therapeutics, LLC v. Granules Pharmaceuticals, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-08-12 | 10 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,751 B2 ;10,226,423 B1 ;10,383,…2020 25 March 2022 1:20-cv-00898 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-07-01 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,751 B2 ;10,226,423 B1. (sam) (…2020 25 March 2022 1:20-cv-00898 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-05-05 | 40 | Order - -Memorandum and Order | infringement of U.S. Patent Nos. 9,907,751 (“the ’751 patent”), 10,226,423 (“the *423 patent”), 10,383,820 (… (“the ’820 patent’) and 10,383,821 (“the °821 patent”) (collectively, the “patents-in-suit”). (D.I. 9…responsible for reviewing patent applications and submissions to the United States Patent and Trademark Office…Naomi Visnhupad are the named co-inventors of the patents-in-suit, which cover colchicine solutions and methods…drug, Gloperba®, prior to the expiration of the patents-in-suit. (/d. at J 1) 2. Romeg is a small company | External link to document |
| 2022-04-25 | 56 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Numbers: 9,907,751 B2; 10,226,423 81; 10,383,830…2020 25 March 2022 1:20-cv-00898 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
